ribonucleas
l
oligoadenyl
synthetas
influenza
viru
innat
immun
inflammasom
autophagi
phosphodiesteras
cell
migrat
b
r
c
ever
sinc
discoveri
exist
interferon
ifn
regul
ribonucleas
signific
advanc
made
understand
mechan
associ
regulatori
effect
action
studi
initi
uniqu
endoribonucleas
current
known
ribonucleas
l
rnase
l
l
stand
latent
key
develop
includ
discoveri
rnase
l
signal
pathway
structur
character
molecular
clone
rnase
l
implic
antivir
antibacteri
defens
well
hereditari
prostat
cancer
rnase
l
activ
link
oligoadenyl
synthes
oligoadenyl
synthetas
oass
famili
ifnregul
pathogen
recognit
receptor
sens
doublestrand
rna
activ
rnase
l
cleav
singl
strand
rna
includ
viral
rna
cellular
rna
catalyt
activ
rnase
l
found
lead
activ
sever
cellular
signal
pathway
includ
involv
autophagi
apoptosi
ifnb
product
inflammasom
activ
lead
secret
inhibit
cell
migrat
cell
adhes
review
highlight
newest
advanc
understand
catalyt
role
rnase
l
context
differ
cellular
pathway
extend
scope
find
discuss
potenti
therapeut
target
antimicrobi
drug
develop
endoribonucleas
essenti
divers
physiolog
process
includ
control
gene
express
regul
rna
process
turnov
cellular
stress
respons
antimicrobi
defens
inflamm
often
oper
close
control
mechan
maintain
normal
cellular
homeostasi
ribonucleas
l
rnase
l
classic
exampl
tightli
regul
endoribonucleas
control
ifninduc
oligoadenyl
synthetas
oass
doublestrand
rna
dsrna
review
rnase
l
previous
known
depend
ribonucleas
metal
ionindepend
endoribonucleas
molecular
weight
kda
function
typeiiii
ifnregul
oasrnas
l
pathway
oasrnas
l
fig
pathway
discov
one
first
ifndepend
antivir
pathway
character
oass
ifniiiiinduc
gene
express
low
basal
level
mani
cell
type
except
immun
cell
macrophag
virusinfect
cell
induc
product
typei
ifn
activ
jakstat
signal
lead
induct
hundr
gene
classifi
member
ifnstimul
gene
famili
includ
oass
oasl
act
pathogen
recognit
receptor
sens
dsrna
activ
synthesi
phosphoryl
link
oligoadenyl
atp
link
oligoadenyl
chemic
structur
p
x
n
x
n
commonli
refer
act
second
messeng
bind
monomer
rnase
l
activ
dimer
format
natur
occur
contain
three
phosphoryl
group
end
howev
monophosphoryl
end
also
found
activ
rnase
l
vitro
condit
activ
rnase
l
cleav
cellular
viral
rna
within
singlestrand
region
predominantli
end
un
dinucleotid
preferenti
uu
ua
produc
rna
product
oh
group
cyclic
phosphat
end
rna
degrad
directli
indirectli
activ
subsequ
event
fig
includ
elimin
viral
genom
inhibit
cellular
viral
protein
synthesi
activ
sever
cellular
signal
pathway
includ
involv
autophagi
apoptosi
senesc
ifnb
product
activ
part
antivir
mechan
review
first
highlight
recent
discoveri
ribonucleas
function
rnase
l
includ
activ
target
certain
rna
comment
implic
sever
cellular
event
potenti
target
novel
therapeut
intervent
rnase
l
first
clone
constitut
express
everi
human
cell
type
inact
conform
mous
cell
express
slightli
induc
ifn
stimul
human
rnase
l
contain
amino
acid
three
domain
ntermin
ankyrin
repeat
domain
ard
contain
one
partial
eight
complet
ankyrin
repeat
domain
ii
protein
kinaselik
domain
pkl
kinas
homolog
domain
lack
conserv
dfg
motif
found
protein
kinas
contain
dfd
sequenc
similar
protein
kinas
far
kinas
activ
report
pkl
henc
rnase
l
consid
pseudokinas
pkl
domain
consist
bilob
fold
short
ntermin
lobe
nlobe
larger
ctermin
lobe
clobe
iii
extend
rigid
protrus
pkl
clobe
ctermin
nucleas
domain
kinas
homolog
domain
kinas
extens
nucleas
ken
domain
structur
similar
metal
ionindepend
endoribonucleas
activ
endoplasm
stress
respons
homolog
suggest
rnase
l
may
share
similar
catalyt
mechan
precis
mechan
rnase
l
activ
elucid
determin
crystal
structur
fulllength
dimer
rnase
l
complex
atp
analog
earli
structur
studi
identifi
two
differ
bind
site
ankd
ankyrin
domain
ankd
contrast
crystal
structur
bound
fulllength
rnase
l
provid
evid
bind
ankrepeat
domain
nlobe
pkl
domain
facilit
dimer
atp
adp
bind
pseudokinas
site
lead
format
singl
close
conform
activ
form
rnase
l
detail
studi
ribonucleas
activ
rnase
l
target
highlight
follow
section
oasrnas
l
pathway
activ
dsrna
ifn
signal
among
oass
sens
dsrna
effici
induc
synthesi
atp
bind
rnase
l
monom
activ
dimer
format
activ
conform
rnase
l
activ
rnase
l
degrad
cellular
viral
rna
lead
restrict
viru
replic
sever
cellular
viral
protein
inhibit
oasrnas
l
pathway
differ
stage
sever
cellular
viral
inhibitor
oasrnas
l
pathway
identifi
tabl
inhibitor
act
differ
level
sequest
dsrna
thu
prevent
suppress
oa
activ
directli
bind
inhibit
rnase
l
degrad
molecul
henc
inhibit
dimer
ribonucleas
activ
rnase
l
viral
infect
rnase
l
degrad
viral
cellular
rna
singlestrand
region
includ
rrna
intact
ribosom
mani
perhap
virus
evolv
acquir
strategi
antagon
oasrnas
l
pathway
evad
antivir
innat
immun
fig
inhibitor
rnase
l
encod
wide
differ
type
virus
indic
rnase
l
target
varieti
virus
influenza
viru
iav
nonstructur
protein
contain
ntermin
rnabind
domain
bind
sequest
dsrna
activ
oa
rnase
l
inhibit
iav
replic
cleav
viral
genom
rna
site
encod
pa
protein
critic
viral
replic
similar
mechan
herp
simplex
viru
type
gene
product
vaccinia
viru
vacv
protein
bind
dsrna
inhibit
innat
immun
respons
recent
two
separ
studi
found
vacv
encod
decap
enzym
capabl
degrad
methyl
mrna
cap
structur
make
suscept
cellular
exonucleas
infect
catalyt
mutant
virus
significantli
increas
dsrnainduc
activ
oa
pkr
similar
mutat
addit
protein
transmiss
gastroenter
coronaviru
tgev
bind
protein
phosphatas
catalyt
subunit
inhibit
dephosphoryl
protein
kinas
r
pkr
rrna
degrad
rnase
l
viral
protein
bind
monomer
rnase
l
prevent
dimer
l
protein
theiler
murin
encephalomyel
viru
tmev
picornaviru
bind
ankyrin
domain
murin
rnase
l
inhibit
bind
rnase
l
activ
interestingli
l
protein
speciesspecif
bind
murin
human
rnase
l
phylogenet
conserv
highli
structur
rna
within
open
read
frame
polioviru
group
c
enterovirus
also
serv
competit
inhibitor
rnase
l
cirna
cirna
impair
bind
instead
act
competit
inhibitor
rnase
domain
inhibitori
function
requir
put
emotif
hh
kiss
loop
increas
number
virus
identifi
encod
phosphodiesteras
pde
directli
degrad
activ
molecul
review
pde
belong
superfamili
protein
character
two
conserv
hisxthrser
motif
activ
site
nonstructur
protein
group
coronaviru
mous
hepat
viru
mhv
member
viral
ligt
famili
necessari
replic
strain
mhv
liver
infect
mice
well
liver
pathogenesi
degrad
vitro
catalyt
mutant
histidin
viru
significantli
lower
titer
compar
wild
type
viru
vivo
contrast
rnase
l
knockout
mice
virus
replic
similarli
suggest
directli
act
oasrnas
l
similarli
rotaviru
rva
encod
viral
protein
structur
homolog
ctermin
domain
although
evolutionarili
nonrel
virus
degrad
similar
manner
vitro
intact
cell
wherea
mutat
two
conserv
histidin
pde
catalyt
site
prevent
degrad
furthermor
ctermin
domain
restor
function
catalyt
mutant
insert
nonessenti
gene
chimer
mhv
anoth
viral
pde
protein
middl
east
respiratori
syndrom
coronaviru
merscov
structur
homolog
nuclear
protein
also
degrad
abl
restor
function
mutant
chimer
mhv
mutat
pde
region
activ
rnase
l
result
rrna
cleavag
sever
host
pde
also
degrad
fig
tabl
kinas
anchor
protein
cellular
member
superfamili
degrad
vitro
rate
similar
viral
homologu
mhv
rva
central
domain
murin
restor
replic
mutant
mhv
chimer
viru
wherea
mhv
chimera
histidinetoarginin
mutat
hisxthr
motif
central
domain
fail
replic
bone
marrow
macrophag
mice
due
structur
homolog
propos
could
evolutionari
precursor
viral
pde
member
addit
phosphodiesteras
member
exonucleaseendonucleas
phosphatas
famili
local
mitochondria
regul
mrna
turnov
remov
polya
tail
despit
mitochondri
local
sever
studi
shown
antagonist
oasrnas
l
directli
cleav
phosphodiest
bond
vitro
decreas
express
cell
reduc
viral
titer
vacv
emcv
absenc
express
greater
multipl
infect
requir
cytopath
effect
compar
wild
type
cell
furthermor
plasma
membran
ectonucleotid
pyropho
sphatasephosphodiesteras
also
shown
nucleas
activ
degrad
vitro
atp
bind
cassett
also
known
rnase
l
inhibitor
rli
anoth
mammalian
protein
inhibit
oasrnas
l
pathway
report
directli
bind
rnase
l
prevent
bind
induc
viral
infect
emcv
hiv
summari
virus
host
cell
encod
varieti
protein
inhibit
oasrnas
l
pathway
contrast
discuss
known
physiolog
activ
pathway
sinc
discoveri
oasrnas
l
pathway
signific
amount
research
direct
toward
identifi
activ
inhibitor
review
discuss
sever
inhibitor
includ
viral
protein
viral
rna
antagonist
host
protein
identifi
within
last
decad
littl
known
potenti
activ
pathway
far
wellcharacter
known
physiolog
activ
rnase
l
addit
studi
small
molecul
activ
publish
potenc
much
less
subnanomolar
concentr
lead
activ
rnase
l
synthesi
occur
dsrna
bind
activ
ifninduc
oligoadenyl
synthetas
human
oass
includ
l
addit
isoform
due
altern
splice
oass
encod
chromosom
arm
possess
nucleotidyl
transferas
activ
human
oa
l
catalyt
inact
encod
chromosom
review
oa
protein
contain
core
polymeras
b
polb
like
nucleotidyl
transferas
domain
structur
similar
polya
polymeras
ccaad
enzym
cga
howev
oass
cga
known
polymer
nucleotid
orient
although
oa
cga
structur
similar
differ
substrat
recognit
cga
recogn
cytosol
dsdna
bform
catalyz
cyclic
guanosin
monophosphateadenosin
monophosph
cgamp
wherea
oass
activ
dsrna
aform
catalyz
synthesi
hand
human
oa
l
catalyt
inact
oa
domain
ntermin
contain
two
ubiquitinlik
domain
cterminu
present
oa
protein
human
oa
l
shown
promot
antivir
activ
enhanc
rigi
activ
among
oass
contain
one
oa
domain
catalyt
activ
contain
two
three
oa
domain
respect
ctermin
oa
domain
catalyt
activ
review
oa
activ
site
contain
three
aspart
acid
coordin
two
ion
requir
enzym
activ
higher
affin
long
dsrna
segment
catalyt
noncatalyt
domain
involv
dsrna
bind
ctermin
domain
involv
synthesi
synthes
vitro
intact
cell
synthesi
predomin
recent
studi
use
individu
oa
knockout
human
cell
line
identifi
principl
enzym
requir
optim
rnase
l
activ
antivir
mechan
knockout
cell
produc
amount
compar
parent
cell
respons
dsrna
viru
infect
wherea
knockout
cell
complet
defici
synthesi
lack
signific
rnase
l
activ
find
support
prior
studi
shown
exert
antivir
activ
dengu
viru
rnase
ldepend
manner
indic
synthes
activ
suffici
amount
rnase
l
activ
probabl
antivir
function
support
activ
might
possibl
addit
altern
function
well
recombin
protein
report
inhibit
emcv
replic
rnase
lindepend
manner
indic
protein
may
altern
antivir
mechan
besid
dsrna
sens
ifn
signal
littl
inform
avail
possibl
relationship
cellular
pathway
oasrnas
l
activ
nucleotidebind
oligomer
domaincontain
protein
member
nodlik
receptor
famili
nlr
interact
lead
enhanc
activ
rnase
l
poli
ri
poli
rc
induc
human
monocyt
leukemia
cell
line
also
shown
bind
ssrna
activ
ribosom
rna
cleavag
one
hallmark
rnase
l
activ
rnase
l
cleav
cellular
viral
rna
within
singlestrand
region
un
dinucleotid
prefer
order
uu
ua
ug
uc
studi
focus
identifi
rna
target
rnase
l
provid
insight
cellular
viral
target
recent
microarraybas
studi
identifi
certain
target
mrna
regul
rnase
l
activ
mrna
encod
ribosom
protein
found
promin
target
howev
studi
identifi
finit
transcript
either
upregul
downregul
rnase
l
activ
anoth
investig
develop
new
approach
transcriptomewid
profil
rnase
ldepend
decay
rldd
map
hundr
direct
target
nontarget
mrna
human
cell
studi
exclud
rrna
focus
mainli
mrna
target
rnase
l
auuuauauau
motif
enrich
greater
target
rna
compar
nontarget
rna
rldd
also
target
sever
mirnaregul
transcript
indic
rnase
l
may
mimic
effect
mirna
involv
suppress
cell
prolifer
adhes
none
studi
focus
rnase
l
cleavag
site
viral
rna
howev
recent
modifi
rna
sequenc
studi
cooper
colleagu
rnase
l
target
site
cellular
rna
rrna
snrna
also
specif
map
viral
rna
hcv
iav
polio
viru
precis
map
method
use
exploit
cyclic
phosphat
end
cleav
rna
characterist
metal
ionindepend
rnase
employ
cyclic
phosphat
cdna
synthesi
illumina
sequenc
map
rnase
l
target
either
vitro
cleav
rna
rna
virusinfect
cell
unlik
mani
studi
activ
exclud
rrna
rna
sequenc
experi
enrich
mrna
rna
popul
two
studi
intent
retain
rrna
precis
locat
rnase
ltarget
rnase
l
nontarget
cleavag
site
rrna
method
specif
identifi
two
promin
rnase
ldepend
cleavag
site
rna
uu
uu
method
also
uncov
rnase
ldepend
andindepend
cleavag
site
within
ribosom
rna
map
associ
singlestrand
region
ribosom
surfac
addit
method
allow
precis
map
endoribonucleas
cleavag
site
viral
rna
iav
infect
cell
influenza
viru
eight
neg
sens
rna
genom
segment
pa
ha
na
np
ns
segment
encod
one
multipl
viral
protein
requir
viral
replic
pathogenesi
endoribonucleas
cleavag
promin
discret
locat
pa
np
rna
segment
rnase
l
knockdown
reduc
amount
cleavag
larg
number
cleavag
site
detect
within
adjac
area
increas
synonymoussit
conserv
note
rnase
lmediat
cleavag
promin
positivestrand
posit
strand
iav
rna
uridinerich
sequenc
auuuuaggauuugug
cleavag
site
rna
lay
within
area
increas
synonymoussit
conserv
base
downstream
splice
donor
sequenc
cleavag
site
also
occur
frequentlyin
pa
segment
iav
genom
strand
iav
genom
rna
suggest
viral
nucleocapsid
protect
iav
rna
rnase
lmediat
cleavag
within
ribonucleoprotein
complex
promin
cleavag
map
within
specif
region
iav
rna
includ
area
increas
synonymoussit
conserv
neg
strand
npposit
strand
paneg
strand
negativestrand
rna
cleav
discret
region
without
increas
synonymoussit
conserv
compar
segment
ha
na
segment
less
synonymoussit
conserv
therefor
less
suscept
rnase
lmediat
cleavag
viral
packag
signal
tend
uridinerich
sequenc
within
area
increas
synonymoussit
conserv
basi
pattern
synonymoussit
conserv
rnase
l
target
site
might
interest
consid
viral
rna
packag
signal
potenti
target
rnase
l
although
studi
cooper
et
al
precis
map
rnase
l
cleavag
site
viral
rna
cellular
rna
highli
abund
cellular
rna
like
rna
precis
map
rnase
l
implic
induct
autophagi
viral
infect
activ
autophagi
confer
antivir
resist
earli
stage
emcv
infect
promot
viral
replic
later
phase
protein
kinas
r
cjun
kinas
shown
involv
autophagi
activ
howev
exact
mechan
rnase
l
mediat
autophagi
yet
discov
found
rnase
l
activ
essenti
autophagi
induct
result
rrna
cleavag
induc
stress
due
rrna
degrad
ribosom
turnov
might
potenti
caus
rnase
lmediat
autophagi
induct
rnase
l
activ
rnase
l
cleavag
product
particip
crosstalk
autophagi
apoptosi
rnase
l
cleavag
product
activ
switch
apoptosi
caspas
cleavag
beclin
henc
may
trigger
cytochrom
c
releas
mitochondria
rnase
l
activ
dsrna
signal
viral
infect
contribut
ifnb
product
indic
import
role
innat
immun
ribonucleas
function
rnase
l
essenti
effect
ifnb
product
rnase
lmediat
cleavag
product
cellular
viral
rna
less
nt
involv
activ
pathogen
recognit
receptor
rigi
henc
activ
downstream
signal
cascad
ifnb
product
rna
speci
design
suppressor
viru
rna
svrna
cyclic
phosphat
hydroxyl
oh
termini
presenc
termin
phosphat
cleav
rna
essenti
recognit
rlr
riglik
receptor
rigi
calf
intestin
phosphatas
treatment
diminish
svrna
abil
produc
ifnb
moreov
mice
defici
rnase
l
severalfold
reduc
level
ifnb
induct
infect
rna
virus
emcv
sendai
viru
mef
cell
infect
dna
viru
rnase
l
also
induc
product
ifnb
howev
mous
primari
macrophag
rnase
l
neg
regul
ifnb
product
poli
ri
poli
rc
transfect
emcv
infect
compar
mous
embryon
fibroblast
mef
level
differ
oass
mous
primari
macrophag
overal
much
higher
possibl
explain
observ
elev
rnase
l
activ
increas
rnase
l
activ
eventu
lead
cell
death
may
explain
reduc
ifnb
product
macrophag
compar
mef
recent
report
rnase
l
essenti
inflammasom
activ
secret
iav
infect
lpsprime
bone
marrowderiv
primari
dendrit
cell
bmdc
human
monocyt
cell
thioglycolateelicit
primari
periton
macrophag
inflammasom
macromolecular
complex
induc
inflammatori
signal
upon
activ
variou
sensori
signal
includ
pathogenassoci
molecular
pattern
dangerassoci
molecular
pattern
canon
inflammasom
activ
caspas
lead
cleavag
product
matur
cleav
secret
unconvent
pathway
recent
nlr
nonnlr
inflammasom
shown
involv
viral
infect
event
activ
downstream
antivir
respons
review
multidomain
protein
consist
ntpyd
pyrin
domain
central
natch
domain
cterminalleucinerich
repeat
lrr
two
signal
requir
inflammasom
activ
prime
signal
involv
transcript
activ
nfjb
target
gene
includ
caspas
ii
second
signal
requir
assembl
macromolecular
complex
inflammasom
activ
wide
rang
rna
dna
viru
infect
review
also
found
rnase
l
increas
level
bronchoalveolar
lavag
fluid
lung
tissu
iav
infect
observ
rnase
l
activ
effect
signal
inflammasom
prime
lpsprime
mous
bmdc
affect
signal
activ
inflammasom
stabl
express
wildtyp
human
fulllength
rnase
l
ribonucleas
dead
mutant
activ
caspas
secret
rnase
ldefici
cell
viru
infect
transfect
intracellular
deliveri
activ
caspas
secret
cultur
supernat
lpsprime
wild
type
mous
bmdc
rnase
l
ascknockout
bmdc
rnase
lcleav
rna
product
cellular
total
rna
iav
genom
rna
activ
caspas
cultur
supernat
lpsprime
bmdc
wildtyp
mice
rnase
l
knockout
mice
bmdc
asc
knockout
mice
earlier
studi
show
rnase
l
cleavag
product
capabl
activ
pathogen
recognit
receptor
rigi
howev
investig
show
neither
rigi
involv
rnase
lmediat
product
rather
rigilik
receptor
rlr
pathway
adaptor
known
mav
play
essenti
role
product
viral
infect
studi
also
implic
involv
mav
inflammasom
activ
addit
data
suggest
presenc
cyclic
phosphat
end
cleav
rna
essenti
inflammasom
activ
inflammasom
pathway
shown
activ
cytosol
deliveri
differ
rna
molecul
includ
dsrna
analogu
poli
ri
poli
rc
bacteri
rna
viral
rna
molecul
dexdhbox
rna
helicas
helicas
ctype
domain
like
rigi
lack
card
domain
act
upstream
sensor
bind
cytosol
rna
interact
mav
found
rnase
lcleav
rna
directli
interact
activ
associ
rna
mav
also
found
presenc
cyclic
phosphat
end
cleavag
product
essenti
interact
rnase
l
shrna
downregul
cell
inhibit
caspas
activ
secret
upon
infect
vesicular
stomat
viru
vsv
iav
transfect
poli
ri
poli
rc
although
rnase
l
primarili
act
antivir
immun
also
found
protect
bacteri
infect
specif
escherichia
coli
bacillu
anthraci
infect
rnase
ldefici
mice
speci
increas
bacteri
load
mortal
comparison
wildtyp
mice
microarray
profil
show
rnase
l
defici
enhanc
stabil
cathepsin
e
mrna
endosom
aspartyl
proteinas
macrophag
higher
express
cathepsin
e
link
decreas
level
requir
phagosom
matur
late
endosom
fuse
lysosom
elimin
bacteria
phagocytosi
decreas
lamp
level
rnase
ldefici
macrophag
associ
accumul
phagocyt
vacuol
reduc
bacteri
clearanc
anoth
studi
report
rnase
l
mediat
protect
dextran
sulfat
sodium
dss
induc
coliti
colitisassoci
cancer
mice
dsstreat
rnasel
mice
significantli
higher
mortal
clinic
morbid
score
delay
infiltr
leukocyt
reduc
express
ifnb
proinflammatori
cytokin
tnfa
compar
dsstreat
wildtyp
mice
moreov
dssazoxymethanetr
rnase
l
mice
display
higher
tumor
burden
compar
wildtyp
mice
find
indic
oasrnas
l
pathway
contribut
mainten
innat
immun
signal
within
intestin
environ
studi
also
shown
enteropathogen
e
coli
epec
infect
inhibit
rnase
l
activ
type
iii
secret
system
help
epec
evad
ifninduc
antibacteri
activ
intestin
epitheli
cell
line
infect
epec
strain
show
higher
rnase
l
activ
ifnb
product
rnase
ldepend
manner
compar
infect
wild
type
epec
indic
novel
role
ifnb
rnase
l
barrier
function
intestin
epitheli
cell
target
epec
secret
system
find
reinforc
potenti
oasrnas
l
system
serv
critic
therapeut
candid
treat
enter
infect
gastrointestin
tract
diseas
evidenc
earlier
genet
studi
rnase
l
also
link
hereditari
prostat
cancer
rnase
l
gene
rnase
l
identifi
candid
hereditari
prostat
cancer
locu
human
chromosom
combin
posit
clone
candid
gene
approach
sinc
howev
sever
studi
found
posit
associ
associ
hereditari
prostat
cancer
mutat
variant
rnase
l
gene
one
possibl
explan
includ
influenc
environment
factor
microbi
popul
may
regul
activ
rnase
l
addit
associ
prostat
cancer
mutat
rnase
l
gene
implic
increas
risk
cancer
includ
nonmelanoma
skin
cancer
head
neck
uterin
cervix
breast
pancreat
hereditari
nonpolyposi
colorect
cancer
recent
rnase
l
activ
link
sever
cellular
process
may
contribut
develop
cancer
includ
apoptosi
autophagi
inflamm
suppress
mobil
genet
element
earlier
studi
demonstr
prostat
cancer
cell
line
lncap
express
higher
level
cellular
rna
molecul
capabl
bind
activ
oass
normal
prostat
epitheli
cell
activ
oa
identifi
mrna
raf
kinas
inhibitor
protein
poli
rc
bind
protein
human
endogen
retroviru
envelop
rna
studi
also
show
mrna
level
elev
prostat
cancer
progress
rnase
l
report
influenc
activ
filamin
affect
actin
cytoskeleton
format
therebi
inhibit
viru
entri
viral
infect
howev
rnase
l
releas
filamin
complex
enabl
activ
nucleasedepend
antivir
function
may
involv
process
cell
adhes
cell
motil
recent
rnase
l
defici
found
enhanc
cell
migrat
inactiv
nucleas
mutant
rnase
l
lack
catalyt
activ
fail
suppress
cell
migrat
cell
highli
metastat
prostat
cancer
cell
line
express
nucleas
dead
mutant
mous
rnase
l
partial
restor
inhibit
cell
migrat
comparison
wildtyp
mous
rnase
l
express
rnase
l
defici
mef
cell
find
suggest
nucleasedepend
andindepend
properti
rnase
l
may
involv
regul
cell
migrat
mef
transfect
cell
rnase
l
activ
also
suppress
cell
migrat
provid
evid
rnase
l
catalyt
activ
necessari
process
prostat
cancer
cell
line
contrast
anoth
report
show
rnase
l
defici
decreas
migrat
bone
marrowderiv
macrophag
may
possibl
due
cell
type
differ
mef
catalyt
noncatalyt
domain
rnase
l
play
role
inhibit
cell
migrat
wherea
cell
nucleas
domain
show
promin
effect
exact
mechan
ifn
regul
rnase
l
suppress
cell
migrat
remain
determin
howev
certain
find
begun
reveal
featur
process
rna
cleavag
product
gener
rnase
l
previous
shown
activ
innat
immun
signal
mechan
rigi
rlr
mavslik
receptor
contrast
sirna
mediat
regul
rigi
mav
cell
affect
cell
migrat
result
indic
rnase
lmediat
decay
mrna
encod
cell
adhes
migrat
protein
appear
key
mechan
rnase
lmediat
inhibit
cell
migrat
rnase
ldepend
mrna
decay
select
affect
transcript
regul
microrna
like
mir
neg
regul
mammalian
cell
adhes
prolifer
rnase
lmediat
decay
mirna
target
may
also
potenti
mimic
effect
mirna
act
suppressor
prolifer
adhes
mammalian
cell
studi
extend
known
biolog
role
activ
rnase
l
inhibit
cell
migrat
adhes
prolifer
provid
explan
propos
link
mutat
variant
rnase
l
gene
increas
cancer
risk
rnase
l
uniqu
ifnregul
endoribonucleas
serv
import
mediat
antivir
innat
immun
possibl
role
antibacteri
defens
prostat
cancer
past
decad
wit
remark
advanc
understand
rnase
l
biolog
activ
probe
studi
rnase
l
structur
function
provid
insight
mode
action
biolog
role
also
sever
cellular
pathway
implic
directli
indirectli
requir
protect
host
variou
infecti
agent
allow
increas
control
host
inflamm
relat
diseas
includ
cancer
target
optimum
rnase
l
activ
may
provid
potenti
platform
develop
broadspectrum
antimicrobi
therapi
inflammatori
diseas
cancer
